NeuroDerm Ltd (NeuroDerm) is a clinical stage pharmaceutical company that focuses on the development of drugs for the treatment of Parkinson’s disease and central nervous system (CNS) disorders through proprietary reformulations of its existing drugs. The company’s levodopa/carbidopa (LD/CD) product candidates include ND0612L, intended for moderate Parkinson’s diseases and ND0612H, for severe Parkinson’s disease. It also develops ND0701, intended for patients with severe Parkinson’s disease and ND0801, a product candidate intended for the treatment of cognitive disorders associated with CNS diseases including attention deficit disorder/attention deficit hyperactivity disorder, alzheimer’s disease, and other diseases. NeuroDerm is headquartered in Rehovot, Israel.
NeuroDerm Ltd Key Recent Developments
Aug 03, 2017: NeuroDerm Announces Second Quarter 2017 Financial Results
May 11, 2017: NeuroDerm Announces First Quarter 2017 Financial Results
Mar 30, 2017: NeuroDerm Announces Fourth Quarter and Full Year 2016 Financial Results
This comprehensive SWOT profile of NeuroDerm Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of NeuroDerm Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- NeuroDerm Ltd - Key Information
- NeuroDerm Ltd - Overview
- NeuroDerm Ltd - Key Employees
- NeuroDerm Ltd - Key Employee Biographies
- NeuroDerm Ltd - Key Operational Heads
- NeuroDerm Ltd - Major Products and Services
- NeuroDerm Ltd - History
- NeuroDerm Ltd - Company Statement
- NeuroDerm Ltd - Locations And Subsidiaries
- NeuroDerm Ltd - Key Manufacturing facilities
- Head Office
- Other Locations & Subsidiaries
- NeuroDerm Ltd - Business Description
- NeuroDerm Ltd - Corporate Strategy
- NeuroDerm Ltd - SWOT Analysis
- SWOT Analysis - Overview
- NeuroDerm Ltd - Strengths
- NeuroDerm Ltd - Weaknesses
- NeuroDerm Ltd - Opportunities
- NeuroDerm Ltd - Threats
- NeuroDerm Ltd - Key Competitors
- NeuroDerm Ltd - Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Ratio Definitions
List of Tables
- NeuroDerm Ltd, Key Information
- NeuroDerm Ltd, Key Ratios
- NeuroDerm Ltd, Share Data
- NeuroDerm Ltd, Major Products and Services
- NeuroDerm Ltd, History
- NeuroDerm Ltd, Key Employees
- NeuroDerm Ltd, Key Employee Biographies
- NeuroDerm Ltd, Key Operational Heads
- NeuroDerm Ltd, Other Locations
- NeuroDerm Ltd, Subsidiaries
- NeuroDerm Ltd, Key Manufacturing facilities
- NeuroDerm Ltd, Key Competitors
- NeuroDerm Ltd, SWOT Analysis
- NeuroDerm Ltd, Ratios based on current share price
- NeuroDerm Ltd, Annual Ratios
- NeuroDerm Ltd, Interim Ratios
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- NeuroDerm Ltd, Performance Chart
- NeuroDerm Ltd, Ratio Charts